CAP-100

CAT:
931-T9901A-961-01
Size:
1 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
CAP-100 - image 1

CAP-100

  • Target :

    CCR
  • Related Pathways :

    GPCR/G Protein|||Microbiology/Virology|||Immunology/Inflammation
  • Bioactivity :

    CAP-100 is a monoclonal antibody targeting CCR7. It neutralizes the ligand binding site and signaling of CCR7. This compound effectively inhibits migration, extravasation, homing, and survival in chronic lymphocytic leukemia (CLL) samples induced by CCR7. CAP-100 can mediate potent tumor cell killing through host immune mechanisms and exhibits favorable toxicity profiles in related hematopoietic cell subsets. It is involved in research on antitumor activity and diseases like chronic lymphocytic leukemia (CLL) .
  • Shipping Conditions :

    Cool pack
  • Storage Temperature :

    -20°C

Featured Selection

Popular Products

Discover our most sought-after biotechnology products, trusted by researchers worldwide